Today’s highlights are from White Coat, Black Art. This week, the show had a look at the journey a new prescription drug takes from research to testing to approval to sales. First stop, the Canadian Expert Drug Advisory Committee. Members weigh the costs and benefits of new drugs and recommend whether or not the provinces should pay for them, effectively sealing each drug's fate as a blockbuster or a dud. We'll also hear about backroom deals that provinces strike with drug companies.

[ Tue, 23 Sep 2008 00:00:00 GMT ]

Listen

Download

Listen on your iPhone